I. Lo

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma

I. Ng, C. Tang, K. Chok, 2020, Hepatology.

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma

P. Sham, I. Ng, C. C. Wong, 2021, Nature Communications.

TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication

Miao Li, I. Ng, C. Tang, 2016, Gut.

RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma.

I. Ng, C. C. Wong, C. Tang, 2020, Journal of hepatology.

Title TSC 1 / 2 mutations define a molecular subset of HCC withaggressive behaviour and treatment implication

Miao Li, I. Ng, C. Tang, 2017 .

Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma

Eva K. Lee, D. Ho, Y. Tsui, 2024, Theranostics.

Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC Cells

C. Tang, Eva K. Lee, K. Sze, 2024, Cellular and molecular gastroenterology and hepatology.